Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma.
Invest New Drugs. 2006 Nov;24(6):543-6. doi: 10.1007/s10637-006-9208-z.
Invest New Drugs. 2006.
PMID: 16832603
Clinical Trial.
Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma.
Patel PH, Kondagunta GV, Schwartz L, Ishill N, Bacik J, DeLuca J, Russo P, Motzer RJ.
Patel PH, et al.
Invest New Drugs. 2008 Jun;26(3):273-6. doi: 10.1007/s10637-007-9107-y. Epub 2007 Dec 27.
Invest New Drugs. 2008.
PMID: 18161005
Clinical Trial.
Item in Clipboard
Phase II trial of pegylated interferon-alpha 2b in patients with advanced renal cell carcinoma.
Feldman DR, Kondagunta GV, Schwartz L, Patil S, Ishill N, DeLuca J, Russo P, Motzer RJ.
Feldman DR, et al.
Clin Genitourin Cancer. 2008 Mar;6(1):25-30. doi: 10.3816/cgc.2008.n.004.
Clin Genitourin Cancer. 2008.
PMID: 18501079
Clinical Trial.
Item in Clipboard
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation.
Patil S, Ishill N, Deluca J, Motzer RJ.
Patil S, et al.
Cancer. 2010 Jan 15;116(2):347-54. doi: 10.1002/cncr.24713.
Cancer. 2010.
PMID: 19921736
Free article.
Item in Clipboard
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ.
Kondagunta GV, et al.
J Clin Oncol. 2007 Jan 1;25(1):85-90. doi: 10.1200/JCO.2006.06.9401.
J Clin Oncol. 2007.
PMID: 17194908
Clinical Trial.
Item in Clipboard
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma.
Carlo MI, Molina AM, Lakhman Y, Patil S, Woo K, DeLuca J, Lee CH, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH.
Carlo MI, et al.
Oncologist. 2016 Jul;21(7):787-8. doi: 10.1634/theoncologist.2016-0145. Epub 2016 Jun 10.
Oncologist. 2016.
PMID: 27286790
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite